• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用抗足细胞毒素单克隆抗体PcMab-47进行的免疫组织化学分析显示足细胞毒素在口腔鳞状细胞癌中表达。

Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas.

作者信息

Itai Shunsuke, Yamada Shinji, Kaneko Mika K, Harada Hiroyuki, Kato Yukinari

机构信息

1 Department of Antibody Drug Development, Tohoku University Graduate School of Medicine , Miyagi, Japan .

2 Department of Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University , Tokyo, Japan .

出版信息

Monoclon Antib Immunodiagn Immunother. 2017 Oct;36(5):220-223. doi: 10.1089/mab.2017.0030. Epub 2017 Sep 5.

DOI:10.1089/mab.2017.0030
PMID:28873000
Abstract

Podocalyxin is a CD34-related type I transmembrane protein that is highly glycosylated with N-glycan, O-glycan, and keratan sulfate. Podocalyxin was originally found in the podocytes of rat kidney and is reportedly expressed in many types of tumors, including brain tumors, colorectal cancers, and breast cancers. Overexpression of podocalyxin is an independent predictor of progression, metastasis, and poor outcome. We recently immunized mice with recombinant human podocalyxin, which was produced using LN229 glioblastoma cells, and produced a novel antipodocalyxin monoclonal antibody (mAb), PcMab-47, which reacts with endogenous podocalyxin-expressing cancer cell lines and normal cell lines independent of glycosylation in Western blot, flow cytometry, and immunohistochemical analyses. In this study, we performed immunohistochemical analysis against oral cancers using PcMab-47. PcMab-47-stained oral squamous cell carcinoma cells in a cytoplasmic pattern and detected 26/38 (68.4%) of oral squamous cell carcinoma cells on tissue microarrays. These results indicate that PcMab-47 is useful in detecting podocalyxin of oral cancers for immunohistochemical analysis.

摘要

足细胞蛋白是一种与CD34相关的I型跨膜蛋白,高度糖基化,含有N-聚糖、O-聚糖和硫酸角质素。足细胞蛋白最初在大鼠肾脏的足细胞中发现,据报道在多种肿瘤中表达,包括脑肿瘤、结直肠癌和乳腺癌。足细胞蛋白的过表达是进展、转移和不良预后的独立预测指标。我们最近用重组人足细胞蛋白免疫小鼠,该重组人足细胞蛋白是用LN229胶质母细胞瘤细胞产生的,并产生了一种新型抗足细胞蛋白单克隆抗体(mAb),即PcMab-47,在蛋白质印迹、流式细胞术和免疫组织化学分析中,它能与内源性表达足细胞蛋白的癌细胞系和正常细胞系反应,且与糖基化无关。在本研究中,我们用PcMab-47对口腔癌进行了免疫组织化学分析。PcMab-47以细胞质模式对口腔鳞状细胞癌细胞进行染色,并在组织微阵列上检测到38个口腔鳞状细胞癌细胞中的26个(68.4%)。这些结果表明,PcMab-47可用于免疫组织化学分析检测口腔癌的足细胞蛋白。

相似文献

1
Immunohistochemical Analysis Using Antipodocalyxin Monoclonal Antibody PcMab-47 Demonstrates Podocalyxin Expression in Oral Squamous Cell Carcinomas.使用抗足细胞毒素单克隆抗体PcMab-47进行的免疫组织化学分析显示足细胞毒素在口腔鳞状细胞癌中表达。
Monoclon Antib Immunodiagn Immunother. 2017 Oct;36(5):220-223. doi: 10.1089/mab.2017.0030. Epub 2017 Sep 5.
2
PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.PcMab-47:用于免疫组织化学的新型抗人足突细胞毒素单克隆抗体。
Monoclon Antib Immunodiagn Immunother. 2017 Apr;36(2):50-56. doi: 10.1089/mab.2017.0008. Epub 2017 Apr 6.
3
47-mG: A Mouse IgG-Type of PcMab-47 Useful for Detecting Podocalyxin in Esophageal Cancers by Immunohistochemistry.47-mG:一种小鼠IgG型的PcMab-47,可通过免疫组织化学检测食管癌中的足细胞标记蛋白
Monoclon Antib Immunodiagn Immunother. 2018 Jun;37(3):158-161. doi: 10.1089/mab.2018.0003. Epub 2018 Apr 9.
4
Anti-Podocalyxin Monoclonal Antibody 47-mG Detects Lung Cancers by Immunohistochemistry.抗足突细胞粘附分子单克隆抗体47-mG通过免疫组织化学检测肺癌。
Monoclon Antib Immunodiagn Immunother. 2018 Apr;37(2):91-94. doi: 10.1089/mab.2018.0002. Epub 2018 Mar 14.
5
Determination of critical epitope of PcMab-47 against human podocalyxin.抗人足细胞表面蛋白的PcMab - 47关键表位的测定
Biochem Biophys Rep. 2018 Apr 24;14:78-82. doi: 10.1016/j.bbrep.2018.04.003. eCollection 2018 Jul.
6
A Cancer-Specific Monoclonal Antibody against Podocalyxin Exerted Antitumor Activities in Pancreatic Cancer Xenografts.一种针对 Podocalyxin 的癌症特异性单克隆抗体在胰腺癌异种移植瘤中发挥了抗肿瘤活性。
Int J Mol Sci. 2023 Dec 21;25(1):161. doi: 10.3390/ijms25010161.
7
Epitope Mapping of a Cancer-Specific Anti-Podocalyxin Monoclonal Antibody (PcMab-60) Using Enzyme-Linked Immunosorbent Assay and Surface Plasmon Resonance.使用酶联免疫吸附测定法和表面等离子体共振对一种癌症特异性抗足细胞标记蛋白单克隆抗体(PcMab-60)进行表位作图
Monoclon Antib Immunodiagn Immunother. 2021 Oct;40(5):227-232. doi: 10.1089/mab.2021.0030.
8
Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.抗足突膜联蛋白抗体chPcMab-47在结直肠癌小鼠异种移植模型中发挥抗肿瘤活性。
Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):157-162. doi: 10.1089/mab.2017.0020. Epub 2017 Jun 30.
9
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.抗足突细胞毒素抗体在口腔鳞状细胞癌小鼠异种移植模型中通过抗体依赖性细胞毒性发挥抗肿瘤作用。
Oncotarget. 2018 Apr 27;9(32):22480-22497. doi: 10.18632/oncotarget.25132.
10
A cancer-specific anti-podocalyxin monoclonal antibody (60-mG-f) exerts antitumor effects in mouse xenograft models of pancreatic carcinoma.一种癌症特异性抗足细胞毒素单克隆抗体(60-mG-f)在胰腺癌小鼠异种移植模型中发挥抗肿瘤作用。
Biochem Biophys Rep. 2020 Oct 10;24:100826. doi: 10.1016/j.bbrep.2020.100826. eCollection 2020 Dec.

引用本文的文献

1
Development of chimeric antigen receptor T cells targeting cancer-expressing podocalyxin.靶向表达癌胚足细胞蛋白的嵌合抗原受体T细胞的开发。
Regen Ther. 2025 Jan 4;28:292-300. doi: 10.1016/j.reth.2024.12.010. eCollection 2025 Mar.
2
Targeting a Tumor-Specific Epitope on Podocalyxin Increases Survival in Human Tumor Preclinical Models.靶向足突细胞粘附分子上的肿瘤特异性表位可提高人类肿瘤临床前模型的生存率。
Front Oncol. 2022 May 4;12:856424. doi: 10.3389/fonc.2022.856424. eCollection 2022.
3
Analysis of the correlation of the expression level of hypoxia-inducible factor-1α with the glycosylation of oral squamous cell carcinoma.
缺氧诱导因子-1α表达水平与口腔鳞状细胞癌糖基化的相关性分析
Am J Transl Res. 2021 Jun 15;13(6):6686-6693. eCollection 2021.
4
Podocalyxin in Normal Tissue and Epithelial Cancer.正常组织和上皮癌中的足细胞毒素蛋白
Cancers (Basel). 2021 Jun 8;13(12):2863. doi: 10.3390/cancers13122863.
5
Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer.新辅助治疗后组织学反应对胰腺癌中 podocalyxin 作为预后标志物的影响。
Sci Rep. 2021 May 10;11(1):9896. doi: 10.1038/s41598-021-89134-2.
6
PODO447: a novel antibody to a tumor-restricted epitope on the cancer antigen podocalyxin.PODO447:一种针对肿瘤抗原足细胞蛋白相关蛋白上肿瘤限制性表位的新型抗体。
J Immunother Cancer. 2020 Nov;8(2). doi: 10.1136/jitc-2020-001128.
7
A cancer-specific anti-podocalyxin monoclonal antibody (60-mG-f) exerts antitumor effects in mouse xenograft models of pancreatic carcinoma.一种癌症特异性抗足细胞毒素单克隆抗体(60-mG-f)在胰腺癌小鼠异种移植模型中发挥抗肿瘤作用。
Biochem Biophys Rep. 2020 Oct 10;24:100826. doi: 10.1016/j.bbrep.2020.100826. eCollection 2020 Dec.
8
Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma.足突细胞粘附分子在成熟B细胞非霍奇金淋巴瘤进展中的新作用
Cancers (Basel). 2020 Feb 8;12(2):396. doi: 10.3390/cancers12020396.
9
Determination of critical epitope of PcMab-47 against human podocalyxin.抗人足细胞表面蛋白的PcMab - 47关键表位的测定
Biochem Biophys Rep. 2018 Apr 24;14:78-82. doi: 10.1016/j.bbrep.2018.04.003. eCollection 2018 Jul.